Remove Cardio Oncology Remove Heart Transplant Remove Myocardial Infarction
article thumbnail

Highlights of ACC 2024

Cardiology Update

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). Here is our curated list of the top sessions.

Angina 52